Teladoc Inc
$ 5.39
0.37%
16 Mar - close price
- Market Cap 961,557,000 USD
- Current Price $ 5.39
- High / Low $ 5.50 / 5.36
- Stock P/E N/A
- Book Value 7.77
- EPS -1.14
- Next Earning Report 2026-04-29
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.03 %
- ROE -0.14 %
- 52 Week High 9.77
- 52 Week Low 4.40
About
Teladoc Health, Inc. provides business-to-business virtual health care services in the United States and internationally. The company is headquartered in Purchase, New York.
Analyst Target Price
$7.12
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-24 | 2025-10-29 | 2025-07-29 | 2025-04-23 | 2025-02-18 | 2024-10-30 | 2024-07-31 | 2024-04-25 | 2024-02-20 | 2023-10-24 | 2023-07-25 | 2023-04-26 |
| Reported EPS | -0.1034 | -0.28 | -0.1473 | -0.2188 | -0.2451 | -0.19 | -0.28 | -0.49 | -0.17 | -0.35 | -0.4 | -0.42 |
| Estimated EPS | -0.1813 | -0.2572 | -0.2632 | -0.358 | -0.2933 | -0.28 | -0.35 | -0.46 | -0.21 | -0.37 | -0.41 | -0.5 |
| Surprise | 0.0779 | -0.0228 | 0.1159 | 0.1392 | 0.0482 | 0.09 | 0.07 | -0.03 | 0.04 | 0.02 | 0.01 | 0.08 |
| Surprise Percentage | 42.9675% | -8.8647% | 44.035% | 38.8827% | 16.4337% | 32.1429% | 20% | -6.5217% | 19.0476% | 5.4054% | 2.439% | 16% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-04-29 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | -0.31 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: TDOC
2026-03-13 22:09:51
The article provides a stock forecast and price target for Teladoc Health (TDOC) for 2026, based on analysis from 21 Wall Street equities research analysts. Analysts have a consensus "Hold" rating for TDOC, with an average price target of $7.72, suggesting a potential upside of 43.67% from its current price of $5.38. The report details individual analyst ratings, price target changes, and a comparison of Teladoc Health to other medical companies.
2026-03-13 13:51:24
Teladoc Health, Inc. President, U.S. Group Health, Kelly Bliss, was granted 15,596 performance stock units, each representing a contingent right to receive one share of TDOC common stock. These units vest one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments, and the award size was determined by the company's 2025 financial results. The filing also amended a prior Form 4 to correct an earlier reporting error and recorded the conversion of 5,198 performance stock units into common stock.
2026-03-13 13:51:24
Teladoc Health (TDOC) recently saw a 6.6% stock jump following upbeat Q4 2025 results and analyst upgrades, notably from Deutsche Bank and BofA Securities, driven by renewed optimism for its BetterHelp mental health unit. Analysts view BetterHelp's profitability and user trends as crucial catalysts for Teladoc's potential turnaround, though competitive pressures and a shift towards lower-margin insurance revenue still pose risks. Despite these challenges, Teladoc's narrative projects significant revenue and earnings growth by 2028, with some analysts forecasting a substantial upside to its current stock price.
2026-03-13 13:51:24
Zacks Research has increased its Q1 2026 EPS estimate for Teladoc Health (NYSE:TDOC) to ($0.36) and its FY2026 estimate to ($0.99), indicating an expectation of improving profitability despite continued losses. Analyst sentiment for TDOC is mixed, with a consensus "Hold" rating and an average price target of $7.76, while CEO Charles Divita III recently sold a significant number of shares. The company's stock has been volatile, trading near $5.38.
2026-03-13 10:51:54
Coherent Market Insights has released a report forecasting rapid growth for the US Telehealth Market through 2033. The report, titled "Us Telehealth Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast, 2026-2033," provides a comprehensive analysis including market percentage records, competitive dynamics, regional performance, and long-term growth potential. It identifies key market players such as Teladoc Health Inc. and American Well Corporation, and segments the market by type (Real Time Telehealth, Store And Forward Telehealth, Remote Patient Monitoring) and application (Hospitals, Clinics, Home Healthcare).
2026-03-13 09:51:53
Coherent Market Insights has published a new research study on the Global "Us Telemedicine Market" forecast to 2033, analyzing market patterns, growth drivers, restraints, and future opportunities. The report segments the market by type, application, end-user, and region, identifying key players such as Teladoc Health Inc. and American Well Corporation. It offers insights into competitive landscapes, market share, and regional dynamics to aid businesses in strategic planning.
